Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,454,936
-$6,204,390 QoQ
Shares Held
13,646
-69.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#309
of 652 holders
Holding Since
Dec 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWINBEECH CAPITAL LP holds $19,348,066 across 17 Biotechnology names. INSM ranks #4 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
18,135 | $4,438,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,325 | $4,312,254 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
42,192 | $2,452,620 | |
| 4 | INSM |
INSMED Inc
This page
|
13,646 | $1,454,936 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
31,387 | $1,214,676 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
9,900 | $737,352 | |
| 7 | VERA |
Vera Therapeutics, Inc.
|
16,200 | $695,142 | |
| 8 | CAPR |
Capricor Therapeutics, Inc.
|
28,337 | $682,354 |
All Filings in INSM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,454,936 | 13,646 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $7,659,326 | 44,009 | Shares | Sole | 2026-02-17 | |
| 2023-03-31 | $4,239,772 | 248,667 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $2,283,907 | 106,031 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $799,611 | 34,026 | Shares | Sole | 2022-05-16 | |
| 2020-12-31 | $526,348 | 15,811 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||